Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · HIV/AIDS

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 4 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Bae: AZT/3TC/NVP vs Other Short Course Regimen

Stillbirth · HIV‐infected pregnant women

It is very uncertain whether tonwe‐Gold continued: AZT/3TC/NVP changes stillbirths compared with other Short Course Regimen (very low certainty).

1 finding from 1 review

Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women 2010 · Cochrane Headline outcomes only
RR 0.89 [0.26, 3.08]
1 study · 241 participants
Very low

Bae: AZT/3TC/NVP vs Other Short Course Regimen

Maternal Mortality at Delivery · HIV‐infected pregnant women

1 finding from 1 review

Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 241 participants
Very low

Bae: AZT/3TC/NVP vs Other Short Course Regimen

Mother to Child Transmission at 1 Month · HIV‐infected pregnant women

It is very uncertain whether tonwe‐Gold continued: AZT/3TC/NVP changes mother to Child Transmission of HIV at 1 Month compared with other Short Course Regimen (very low certainty).

1 finding from 1 review

Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women 2010 · Cochrane Headline outcomes only
RR 0.32 [0.04, 2.83]
1 study · 217 participants
Very low

Bae: AZT/3TC/NVP vs Other Short Course Regimen

Mother to Child Transmission at 12 Months · HIV‐infected pregnant women

It is very uncertain whether tonwe‐Gold continued: AZT/3TC/NVP changes mother to Child Transmission of HIV at 12 Months compared with other Short Course Regimen (very low certainty).

1 finding from 1 review

Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women 2010 · Cochrane Headline outcomes only
RR 0.4 [0.11, 1.41]
1 study · 188 participants
Very low